product summary
Loading...
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human IL-13 R alpha 1 Fc Chimera Protein, CF
catalog :
146-IR-100
quantity :
100 ug
price :
394 USD
more info or order :
citations: 4
Reference
Stern L, Gholamin S, Moraga I, Yang X, Saravanakumar S, Cohen J, et al. Engineered IL13 variants direct specificity of IL13Rα2-targeted CAR T cell therapy. Proc Natl Acad Sci U S A. 2022;119:e2112006119 pubmed publisher
Brown C, Aguilar B, Starr R, Yang X, Chang W, Weng L, et al. Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma. Mol Ther. 2018;26:31-44 pubmed publisher
Miller R, Sadhukhan R, Wu C. Development of an in vitro potency bioassay for therapeutic IL-13 antagonists: the A-549 cell bioassay. J Immunol Methods. 2008;334:134-41 pubmed publisher
Andrews A, Bucchieri F, Arima K, Izuhara K, Holgate S, Davies D, et al. Effect of IL-13 receptor alpha2 levels on the biological activity of IL-13 variant R110Q. J Allergy Clin Immunol. 2007;120:91-7 pubmed
product information
brand :
R&D Systems
master code :
146-IR
SKU :
146-IR-100
product name :
Recombinant Human IL-13 R alpha 1 Fc Chimera Protein, CF
description :
The Recombinant Human IL-13 R alpha 1 Fc Chimera Protein, CF from R&D Systems is derived from NS0. The Recombinant Human IL-13 R alpha 1 Fc Chimera Protein, CF has been validated for the following applications: Binding Activity.
target :
IL-13 R alpha 1
category :
Proteins and Enzymes
unit sizes :
100 ug
buffer :
Lyophilized from a 0.2 µm filtered solution in PBS.
conjugate :
Unconjugated
purity :
>90%, by SDS-PAGE under reducing conditions and visualized by silver stain
species :
Human
observed molecular weight :
110 kDa, reducing conditions
theoretical molecular weight :
64 kDa (monomer)
gene symbol :
IL13RA1
details of functionality :
Measured by its binding ability in a functional ELISA. Immobilized rhIL-13 R alpha 1/Fc Chimera at 4 µg/mL (100 µL/well) can bind rhIL-13 with a linear range of 1-100 ng/mL. Optimal dilutions should be determined by each laboratory for each application.
endotoxin note :
<0.10 EU per 1 µg of the protein by the LAL method.
accessionNumbers :
Q5JSL4
applications :
Binding Activity
source :
NS0-derived Recombinant Human IL-13 R alpha 1 Fc Chimera Protein, CF
USD :
394 USD
alt names :
bB128O4.2.1 (interleukin 13 receptor, alpha 1), Cancer/testis antigen 19, CD213A1, CD213a1 antigen, CT19, IL13 receptor alpha-1 chain, IL-13 receptor subunit alpha-1, IL13R, IL13R alpha 1, IL-13R subunit alpha-1, IL-13Ra, IL13RA, IL13RA1, IL-13RA1, IL-13R-alpha-1, interleukin 13 receptor, alpha 1, interleukin-13 receptor subunit alpha-1, NR4
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.